Statin treatment in multiple sclerosis: a systematic review and meta-analysis

CNS Drugs
Gorm Pihl-JensenJette Lautrup Frederiksen

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease that leads to progressive disability. Statins [hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors] are widely prescribed drugs in hypercholesterolemia. They exert immunomodulatory and neurotrophic effects and are attractive candidates for MS treatment due to reliable safety profiles and favorable costs. Studies of statins in a murine MS model and in open-label trials in MS have shown decreased disease severity. Our objective was to assess current evidence to support statin treatment in MS and clinically isolated syndrome (CIS). We conducted a systematic literature review of EMBASE, PubMed, and CINAHL databases, clinical trials registries, and unpublished conference meeting abstracts as well as reference lists between 1 and 8 June 2014 and repeated it on 1 December 2014. Randomized controlled trials (RCTs) of statins, in any form or dosage, as monotherapy or add-on to established therapy in relapsing-remitting MS (RRMS), progressive MS, and CIS were included. Data were extracted using pre-defined fields to measure study quality. Meta-analysis was performed with regards to pre-defined outcome measures of relapse activity, magnetic resonance imaging (MRI) activity, Ex...Continue Reading

References

Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
Sep 7, 1995·The New England Journal of Medicine·J A KobashigawaG A Cogert
Nov 13, 2002·Neurology·E FisherN A Simonian
Mar 11, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·John GreenwoodPeter Adamson
Mar 28, 2003·American Heart Journal·Luther T Clark
Jul 17, 2003·Journal of Neurology·Armando SenaM Graça Morais
May 18, 2004·Lancet·Timothy VollmerInderjit Singh
Aug 21, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Sebastian WolfrumJames K Liao
Apr 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sonia WaicziesFrauke Zipp
Oct 6, 2005·Glia·Hedwich F KuipersPeter J van den Elsen
Mar 18, 2006·The Journal of Clinical Investigation·Olaf StüveScott S Zamvil
Oct 19, 2006·European Journal of Immunology·Raffaella GhittoniCosima T Baldari
Nov 2, 2006·Glia·Veronique E MironJack P Antel
Dec 30, 2006·Nature Reviews. Neuroscience·John A AllenMark M Rasenick
Mar 8, 2008·Stroke; a Journal of Cerebral Circulation·Jovita PonceTeresa Gasull
Mar 28, 2008·Science Signaling·Sonia WaicziesFrauke Zipp
May 6, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xin ZhangSilva Markovic-Plese
Jun 25, 2008·Multiple Sclerosis : Clinical and Laboratory Research·J SellnerH P Mattle
Jul 8, 2008·European Journal of Immunology·Sun J LeeEtty N Benveniste
May 12, 2009·Progress in Neurobiology·Peter J van der MostUlrich L M Eisel
Mar 10, 2011·Annals of Neurology·Chris H PolmanJerry S Wolinsky
Sep 13, 2011·Multiple Sclerosis : Clinical and Laboratory Research·M Mateo Paz SoldánMoses Rodriguez
Sep 17, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Anna TsakiriJette Frederiksen
Mar 31, 2012·Neurology·E WaubantUNKNOWN ITN020AI Study Management Team
May 10, 2012·Journal of Neurology·Christian Philipp KammHeinrich Paul Mattle

❮ Previous
Next ❯

Citations

Jan 20, 2016·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·F PalavraF Reis
Feb 10, 2016·Multiple Sclerosis and Related Disorders·Simon ZhornitskyManu Rangachari
Sep 10, 2015·The Journal of Investigative Dermatology·Alexander EgebergPeter Riis Hansen
Jan 6, 2016·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Afsaneh ShiraniOlaf Stüve
Jul 5, 2016·Cell Reports·Hai LiChristopher E Henderson
Dec 13, 2016·Current Opinion in Neurology·Axel Petzold
Jun 28, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Nasim Sadat PajohanfarBahareh Amin
Feb 3, 2018·Immunology·Robert Zeiser
Sep 2, 2017·Journal of Neurology, Neurosurgery, and Psychiatry·Jonathan I SpencerGabriele C DeLuca
Jul 11, 2019·CNS Drugs·Moritz FörsterDavid Kremer
Aug 2, 2017·The Journal of General Virology·James A CarrollBruce Chesebro
Sep 17, 2018·Histochemistry and Cell Biology·Markus IslingerMichael Schrader
Jan 18, 2019·Viruses·James A Carroll, Bruce Chesebro
Jan 25, 2017·Nature Communications·Stefan A BerghoffGesine Saher
Aug 11, 2019·Immunologic Research·Georgios NtolkerasDimitrios P Bogdanos
Jun 13, 2020·Immunometabolism·Colleen E Hayes, James M Ntambi
Nov 22, 2016·Lipid Insights·Jonathan T DaviesHollie I Swanson
Jul 10, 2018·Current Medicinal Chemistry·Tess DierckxJerome J A Hendriks
Dec 14, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Xinrui ZhengYangang Wang
Mar 11, 2019·Journal of Neuroinflammation·Lukmanee TradtrantipAlan S Verkman
Feb 25, 2020·The Journal of Clinical Investigation·Lindsay M WebbMireia Guerau-de-Arellano
Nov 25, 2020·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·So Young KimHyo Geun Choi
Oct 1, 2019·European Journal of Pharmacology·Niloufar MohammadkhaniEberhard Korsching
Dec 8, 2020·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Georgina Torrandell-HaroRoberta Diaz Brinton
May 1, 2021·Frontiers in Endocrinology·Inés Pineda-TorraElizabeth C Jury
Jul 30, 2021·Acta neurologica Belgica·Fardin NabizadehAbdorreza Naser Moghadasi
Aug 28, 2021·International Journal of Molecular Sciences·Rodica BalasaDoina Manu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.